In the realm of biochemical research and peptide study, the interaction between regulatory neuropeptides and cellular growth remains a focal point of investigation. Among these, the vasoactive intestinal peptide (VIP)—a neurotransmitter—stands out due to its multifaceted roles in the human body. When discussing vasoactive intestinal peptide cancer connections, we are primarily exploring the phenomenon of the VIPoma, a neuroendocrine neoplasm secreting vasoactive intestinal peptide.
The Nature of the VIPoma
A VIPom 21 Nov 2025—A VIPoma is a rare neuroendocrine tumor that overproduces Vasoactive Intestinal Peptide(VIP). · The hallmark symptom is severe, watery diarrhea, Read more a is a rare functional neuroendocrine tumor that typically originates within Vasoactive intestinal peptide represses activation of tumor- the pancreas. These very rare pancreatic neuroendocrine tumors are identified by their autonomous production of VIP. Because VIPomas are neuroendocrine tumors that secrete vasoactive intestinal peptide, they disrupt the normal homeostatic balance of the gastrointestinal tract.
From a research perspective, it is critical to note that while VIP stands for vasoactive intestinal peptide, it is not inherently a malignant marker; rather, it is a hormone that normally assists in relaxing muscles in the stomach and bowel. However, when certain tumors in the pancreas make large amounts of vasoactive intestinal peptide, the resulting physiological impact is profound. This is often referred to as a non-beta pancreatic islet cell tumor secreting vasoactive intestinal peptide.
Researching Cellular Interactions
My interest in this subject stems from the broader study of peptide signaling. It is fascinating to observe how different cellular environments react to this hormone. For instance, some laboratory studies have indicated that vasoactive intestinal peptide (VIP) increases adhesion of renal carcinoma cells, potentially altering how those cells behave within a matrix.
Conversely, other research has suggested that VIP is found to inhibit gastric cancer cells as well as tumor formation in specific models, demonstrating the paradoxical nature of peptide signaling in oncology research. Furthermore, while neu Ganglioneuroblastoma as Vasoactive intestinal ropeptides such as vasoactive intestinal peptide (VIP) can promote tumor growth and activate antiapoptotic signaling in certain dif Functional NETs that secrete high levels ofvasoactive intestinal peptide(VIP) are known as VIPomas and can also be referred to as Verner-Morrison syndrome or Read more ferentiated cancer cells, the context of the tumor microenvironment remains the deciding factor in these outcomes.
Clinical Context and Identification
When identifying a vasoactive intestinal peptide-secreting tumor (VIPoma), researchers look for specific markers. Because VIPoma is a rare functional neuroendocrine tumor, its presentation is often identified by a specific clinical triad involving chronic secretory diarrhea. These rare neuroendocrine tumors of the pancreas that se Cytoprotective effect of neuropeptides on cancer stem cells crete vasoactive intestinal peptide are notoriously complex to diagnose because the tumor's output of the peptide is so high that it overrides standard regulatory feedback loops.
Whether one is looking at a vasoactiv by LU CHEN·2015·Cited by 33—In the present study,VIP is found to inhibit gastric cancer cellsas well as tumor formation in the nude mouse model. We found the depressive Read more e intestinal peptide (VIP) secreting tumor (VIPoma) or other rare functional neuroendocrine tumours, Chronic Diarrhea Caused by Vasoactive Intestinal Peptide the primary mechanism is the overproduction of vasoactive intestinal polypeptide. In the scientific literature, this is also recognized as a Vasoactive intestinal peptide tumor.
Summary of Findings
The study of the vasoactive intestinal peptide (VIP) is essential for understanding how regulatory hormones can influence cellular proliferation. While the vasoactive intestinal peptide (VIP) secreting tumour is a serious subject in endocrinology, the ongoing research into how these peptides interact with various cancer cell lines provides invaluable data for the broader scientific community.
As we continue to analyze how these hormones function, it becomes clear that the regulation of vasoactive intestinal peptide is a delicate balance. Whether it is acting as a neurotransmitter or a signaling molecule in the presence of a tumor, the study of this peptide continues to provide deep insights into the biology of neuroendoc by N Natanzi·2009·Cited by 7—Results and conclusion.Vasoactive intestinal peptide tumoris a rare neoplasm associated with significant morbidity and mortality through Read more rine systems. By separating the physiological role of the peptide from the pathological output of a VIPoma, we gain a clearer understanding of how these complex systems operate.